Differential gene expression profiling of vocal fold polyps and Reinke's edema by complementary DNA microarray

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 9 I, 2006, Pages 703-714

  Duflo, Suzy M ^a,d   Thibeault, Susan L ^a,e   Li, Wenhua ^a   Smith, Marshall E ^a   Schade, Goetz ^b   Hess, Markus M ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d TIMONE HOSPITAL   (France)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Complementary DNA microarray; Gene expression; Polyp; Reflux; Reinke's edema; Voice disorder

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; LARYNX DISORDER; LARYNX EDEMA; LARYNX PAPILLOMATOSIS; MALE; MICROARRAY ANALYSIS; MICROSURGERY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REINKE EDEMA; STROBOSCOPE; VOCAL CORD;

EID: 33749003194     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611500910     Document Type: Article

References (49)

1. Moussallam I, Kotby M, Ghaly A, Nassar A, Barakah M. Histopathological aspects of benign vocal fold lesions associated with dysphonia. In: Kierchner J, ed. Vocal fold histopathology: a symposium. San Diego, Calif: College Hill Press, 1986:65-80.
2. Gray SD. Benign pathologic responses of the larynx. Curr Opin Otolaryngol Head Neck Surg 1997;5:129-32.
3. Courey MS, Shohet JA, Scott MA, Ossoff RH. Immunohistochemical characterization of benign laryngeal lesions. Ann Otol Rhinol Laryngol 1996;105:525-31.
4. Volic SV, Klapan I, Seiwerth S, Ibrahimpasic T. Extracellular matrix of Reinke's space in some pathological conditions. Acta Otolaryngol (Stockh) 2004;124:505-8.
5. Gray SD, Hammond E, Hanson DF. Benign pathologic responses of the larynx. Ann Otol Rhinol Laryngol 1995;104:13-8.
6. Dikkers FG, Nikkels PG. Benign lesions of the vocal folds: histopathology and phonotrauma. Ann Otol Rhinol Laryngol 1995;104:698-703.
7. Marcotullio D, Magliulo G, Pietrunti S, Suriano M. Exudative laryngeal diseases of Reinke's space: a clinicohistopathological framing. J Otolaryngol 2002;31:376-80.
8. Pastuszek P, Krecicki T, Zalesska-Krecicka M, Jelen M, Rak J, Krajewska B. Histological and electron microscopic investigation of Reinke's edema. Pol J Pathol 2003;54:61-4.
9. Roy N, Weinrich B, Tanner K, Corbin-Lewis K, Stemple J. Replication, randomization and clinical relevance: a response to Dworkin and colleagues. J Speech Lang Hear Res 2004;47:358-65.
10. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A 1996;93:10614-9.
11. Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002;8:500-8.
12. Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002;8:68-74.
13. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7.
14. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-40.
15. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
16. Whipple ME, Kuo WP. DNA microarrays in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg 2002;127:196-204.
17. Berger JA, Hautaniemi S, Jarvinen AK, Edgren H, Mitra SK, Astola J, et al. Optimized LOWESS normalization parameter selection for DNA microarray data. BMC Bioinformatics 2004;5:194.
18. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
19. [Erratum in Proc Natl Acad Sci U S A 2001;98:10515.]
20. Duflo S, Thibeault SL, Li W, Shu XZ, Prestwich GD. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng (in press).
21. Jenson SD, Robetorye RS, Bohling SD, et al. Validation of cDNA microarray gene expression data obtained from linearly amplified RNA. Mol Pathol 2003;56:307-12.
22. Epstein CB, Butow RA. Microarray technology - enhanced versatility, persistent challenge. Curr Opin Biotechnol 2000;11:36-41.
23. Powell CS, Wright MM, Jackson RM. p38mapk and MEK1/2 inhibition contribute to cellular oxidant injury after hypoxia. Am J Physiol Lung Cell Mol Physiol 2004;286:L826-L833.
24. Al-Gubory KH, Ceballos-Picot I, Nicole A, et al. Changes in activities of superoxide dismutase, nitric oxide synthase, glutathione-dependent enzymes and the incidence of apoptosis in sheep corpus luteum during the estrous cycle. Biochim Biophys Acta 2005;1725:348-57.
25. Missall TA, Cherry-Harris JF, Lodge JK. Two glutathione peroxidases in the fungal pathogen Cryptococcus neoformans are expressed in the presence of specific substrates. Microbiology 2005;151:2573-81.
26. Inoue Y, Matsuda T, Sugiyama K, Izawa S, Kimura A. Genetic analysis of glutathione peroxidase in oxidative stress response of Saccharomyces cerevisiae. J Biol Chem 1999;274; 27002-9.
27. Yang Y, Cheng JZ, Singhal SS, et al. Role of glutathione S-transferases in protection against lipid peroxidation. Overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation. J Biol Chem 2001;276:19220-30.
28. Le Trong I, Stenkamp RE, Ibarra C, Atkins WM, Adman ET. 1.3-A resolution structure of human glutathione S-transferase with S-hexyl glutathione bound reveals possible extended ligand in binding site. Proteins 2002;48:618-27.
29. Orhan H, Evelo CT, Sahin G. Erythrocyte antioxidant defense response against cigarette smoking in humans - the glutathione S-transferase vulnerability. J Biochem Mol Toxicol 2005;19:226-33.
30. Zhao Z, Reece EA. Nicotine-induced embryonic malformations mediated by apoptosis from increasing intracellular calcium and oxidative stress. Birth Defects Res B Dev Reprod Toxicol 2005;74:383-91.
31. Ozguner F, Koyu A, Cesur G. Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol Ind Health 2005;21:21-6.
32. Liu J, Cui ZS, Luo Y, Jiang L, Man XH, Zhang X. Effect of cyclin G2 on proliferative ability of SGC-7901 cell. World J Gastroenterol 2004;10:1357-60.
33. Seeler JS, Dejean A. The PML nuclear bodies: actors or extras? Curr Opin Genet Dev 1999;9:362-7.
34. Yordy JS, Moussa O, Pei H, Chaussabel D, Li R, Watson DK. SP100 inhibits ETS1 activity in primary endothelial cells. Oncogene 2005;24:916-31.
35. Lopes N, Gregg D, Vasadevan S, Hassainen H, Goldschmidt-Clermont P, Kovacic H. Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling. Mol Cell Biol 2003;23:5401-8.
36. Barker TH, Baneyx G, Cardo-Vila M, et al. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 2005;280:36483-93.
37. Sweetwyne MT, Brekken RA, Workman G, et al. Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies. J Histochem Cytochem 2004;52:723-33.
38. Fujita T, Shiba H, Van Dyke TE, Kurihara H. Differential effects of growth factors and cytokines on the synthesis of SPARC, DNA, fibronectin and alkaline phosphatase activity in human periodontal ligament cells. Cell Biol Int 2004;28:281-6.
39. Chlenski A, Liu S, Guerrero LJ, et al. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Int J Cancer 2006;118:310-6.
40. Yoshioka S, Fujiwara H, Higuchi T, Yamada S, Maeda M, Fujii S. Melanoma cell adhesion molecule (MCAM/CD146) is expressed on human luteinizing granulosa cells: enhancement of its expression by hCG, interleukin-1 and tumour necrosis factor-alpha. Mol Hum Reprod 2003;9:311-9.
41. Dikkers FG, Hulstaert CE, Oosterbaan JA, Cervera-Paz FJ. Ultrastructural changes of the basement membrane zone in benign lesions of the vocal folds. Acta Otolaryngol (Stockh) 1993;113:98-101.
42. Thibeault SL, Hirschi SD, Gray SD. DNA microarray gene expression analysis of a vocal fold polyp and granuloma. J Speech Lang Hear Res 2003;46:491-502.
43. Carlton J, Bujny M, Peter BJ, et al. Sorting nexin-1 mediates tubular endosome-to-TGN transport through coincidence sensing of high-curvature membranes and 3-phosphoinositides. Curr Biol 2004;14:1791-800.
44. Martinez-Gac L, Alvarez B, Garcia Z, Marques M, Arrizabalaga M, Carrera AC. Phosphoinositide 3-kinase and Forkhead, a switch for cell division. Biochem Soc Trans 2004;32: 360-1.
45. Martinez-Gac L, Marques M, Garcia Z, Campanero MR, Carrera AC. Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Biol 2004;24:2181-9.
46. Liu L, Ergun G, Ertan A, Woods K, Sachs I, Younes M. Detection of oxidative DNA damage in oesophageal biopsies of patients with reflux symptoms and normal pH monitoring. Aliment Pharmacol Ther 2003;18:693-8.
47. Nagata T, Takahashi Y, Ishii Y, et al. Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array. Cancer Genet Cytogenet 2003;145:152-60.
48. Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005; 37:182-6.
49. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002;30:41-7.